Casirivimab + imdevimab prevents progression to symptomatic COVID-19
(HealthDay)—For asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR)-positive individuals living with an infected household contact, treatment with the subcutaneous casirivimab ...
Jan 26, 2022
0
4